Publication venue 'Springer Science and Business Media LLC'
Publication date
Field of study No full text
Publication venue
Publication date 01/01/2011
Field of study No full text Non disponibile
Publication venue 'Springer Science and Business Media LLC'
Publication date 01/05/2010
Field of study No full text In February 2010, aztreonam for inhalation solution (Cayston; Gilead) - an inhalable formulation of the monobactam antibiotic aztreonam and lysine - was approved by the US FDA to improve respiratory symptoms in patients with cystic fibrosis infected with Pseudomonas aeruginosa
Publication venue 'Springer Science and Business Media LLC'
Publication date
Field of study No full text
Publication venue 'Springer Science and Business Media LLC'
Publication date 01/01/2012
Field of study No full text
Publication venue 'Springer Science and Business Media LLC'
Publication date
Field of study No full text
Publication venue 'Springer Science and Business Media LLC'
Publication date
Field of study No full text
Publication venue 'Springer Science and Business Media LLC'
Publication date
Field of study No full text
Publication venue 'Springer Science and Business Media LLC'
Publication date
Field of study No full text
Publication venue 'Springer Science and Business Media LLC'
Publication date
Field of study No full text